Skip to product information
1 of 1

Elabscience

SKU:PDMH100086

Recombinant Human Arresten/COL4α1 protein (His tag)

Recombinant Human Arresten/COL4α1 protein (His tag)

Regular price $499.00 USD
Regular price Sale price $499.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Sequence
Fusion tag

A DNA sequence encoding the Human COL4α1 protein (P02462) (Ser1441-Thr1669) was expressed with a C-His.

Introducing the Recombinant Human Arresten/COL4Α1 Protein (HIS TAG), a cutting-edge product meticulously engineered to cater to the diverse needs of the scientific community. This protein, derived from human sources, is a result of advanced recombinant technology, ensuring utmost purity and quality.

The Recombinant Human Arresten/COL4Α1 Protein (HIS TAG) boasts a unique composition, featuring the incorporation of a histidine (HIS) tag. This tag facilitates efficient purification and subsequent identification of the protein, enabling researchers to streamline their experimental processes with utmost precision and accuracy.

Crafted with utmost care, this protein exhibits exceptional stability and solubility, rendering it an ideal choice for a wide array of applications. Its versatility extends to its compatibility with various experimental techniques, including but not limited to Western blotting, ELISA, and protein-protein interaction studies.

Furthermore, the Recombinant Human Arresten/COL4Α1 Protein (HIS TAG) is meticulously characterized, ensuring its conformity to the highest industry standards. Rigorous quality control measures have been implemented throughout its production, guaranteeing batch-to-batch consistency and reliability.

In summary, the Recombinant Human Arresten/COL4Α1 Protein (HIS TAG) stands as a paramount offering in the realm of scientific research. Its unrivaled purity, stability, and compatibility make it an indispensable tool for researchers seeking to unravel the intricacies of protein-protein interactions and related studies. Embrace this exceptional product and elevate your scientific endeavors to unprecedented heights.

View full details